Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials

Abstract

Post hoc pooled analyses suggested that metformin reduced subsequent disease flares in patients with SLE with low disease activity, especially for serologically quiescent patients.